Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Heejung Bang & Hongwei Zhao. (2016) Median-based incremental cost-effectiveness ratios with censored data. Journal of Biopharmaceutical Statistics 26:3, pages 552-564.
Read now
Read now
Heejung Bang & Hongwei Zhao. (2014) Cost-Effectiveness Analysis: A Proposal of New Reporting Standards in Statistical Analysis. Journal of Biopharmaceutical Statistics 24:2, pages 443-460.
Read now
Read now
Articles from other publishers (52)
Marwan Bouras, Amandine Clément, Solène Schirr-Bonnans, Nicolas Mauduit, Morgane Péré, Antoine Roquilly, Valery-Pierre Riche & Karim Asehnoune. (2023) Cost effectiveness and long-term outcomes of dexamethasone administration in major non-cardiac surgery. Journal of Clinical Anesthesia 90, pages 111218.
Crossref
Crossref
Christoph Paul Klapproth, Felix Fischer & Matthias Rose. (2023) Scale agreement, ceiling and floor effects, construct validity, and relative efficiency of the PROPr and EQ-5D-3L in low back pain patients. Health and Quality of Life Outcomes 21:1.
Crossref
Crossref
Suzana Bojic, Nebojsa Ladjevic, Ivan Palibrk, Ivan Soldatovic, Ivana Likic-Ladjevic, Winfried Meissner, Ruth Zaslansky, Ulrike M Stamer, Philipp Baumbach & Dusica Stamenkovic. (2023) Cost-effectiveness of the Perioperative Pain Management Bundle a registry-based study. Frontiers in Public Health 11.
Crossref
Crossref
Chen-Yu Wang, Chih-Hsing Wu, Ho-Min Chen, Jou-Wei Lin, Chih-Cheng Hsu, Yin-Fan Chang, Ta-Wei Tai, Shau-Huai Fu & Jawl-Shan Hwang. (2023) Cost and effectiveness analyses of the anti-osteoporosis medication in patients with hip fracture in Taiwan: A population-based national claims database analysis. Journal of the Formosan Medical Association.
Crossref
Crossref
Naga Simhadri Apparao Polireddi & J. Kavitha. (2023) Effectiveness of automated chatbots for operational support and self-service based on fuzzy classifier for ASD. Soft Computing.
Crossref
Crossref
Annarita Fanizzi, Elisabetta Graps, Domenica Antonia Bavaro, Marco Farella, Samantha Bove, Francesco Campobasso, Maria Colomba Comes, Cristian Cristofaro, Daniele La Forgia, Martina Milella, Serena Iacovelli, Rossella Villani, Rahel Signorile, Alessio De Bartolo, Vito Lorusso & Raffaella Massafra. (2023) Assessing the cost-effectiveness of waiting list reduction strategies for a breast radiology department: a real-life case study. BMC Health Services Research 23:1.
Crossref
Crossref
Anna Zanetti, Garifallia Sakellariou, Antonella Zambon, Greta Carrara, Lisa Argnani, Lorenzo G. Mantovani, Paolo A. Cortesi, Serena Bugatti, Carlomaurizio Montecucco & Carlo A. Scirè. (2022)
Cost‐Effectiveness
of the Early Arthritis Clinic Organizational Model
. Arthritis Care & Research 75:5, pages 1046-1051.
Crossref
Crossref
Aurélie Duruflé, Claire Le Meur, Patrice Piette, Bastien Fraudet, Emilie Leblong & Philippe Gallien. (2023) Cost effectiveness of a telerehabilitation intervention vs home based care for adults with severe neurologic disability: A randomized clinical trial. DIGITAL HEALTH 9.
Crossref
Crossref
C. P. Klapproth, F. Fischer, M. Merbach, M. Rose & A. Obbarius. (2022) Psychometric properties of the PROMIS Preference score (PROPr) in patients with rheumatological and psychosomatic conditions. BMC Rheumatology 6:1.
Crossref
Crossref
Jana Bartakova, Franziska Zúñiga, Raphaëlle-Ashley Guerbaai, Kornelia Basinska, Thekla Brunkert, Michael Simon, Kris Denhaerynck, Sabina De Geest, Nathalie I. H. Wellens, Christine Serdaly, Reto W. Kressig, Andreas Zeller, Lori L. Popejoy, Dunja Nicca, Mario Desmedt & Carlo De Pietro. (2022) Health economic evaluation of a nurse-led care model from the nursing home perspective focusing on residents’ hospitalisations. BMC Geriatrics 22:1.
Crossref
Crossref
Christoph Paul Klapproth, Felix Fischer, Matthias Rose & Maria Margarete Karsten. (2022) Health state utility differed systematically in breast cancer patients between the EORTC QLU-C10D and the PROMIS Preference Score. Journal of Clinical Epidemiology 152, pages 101-109.
Crossref
Crossref
Meriem Fgaier & Zsombor Zrubka. (2022) Cost-effectiveness of using chatbots in healthcare: a systematic review. Cost-effectiveness of using chatbots in healthcare: a systematic review.
Aryana Arsham, Ionut Bebu & Thomas Mathew. (2022) A Bivariate Regression-Based Cost-Effectiveness Analysis. Journal of Statistical Theory and Practice 16:2.
Crossref
Crossref
Marcos Aurélio Fonseca MagalhãesFilhoFilho, Pedro Nazareth AguiarJr.Jr., Milena Brachmans Mascarenhas Neves, Gilberto de Lima LopesJr.Jr. & Auro del Giglio. (2022) Cost-effectiveness analysis of Ado-trastuzumab emtansine for the treatment of residual invasive HER2-positive breast cancer. Einstein (São Paulo) 20.
Crossref
Crossref
Christoph Paul Klapproth, Christopher J. Sidey-Gibbons, José Martinez Valderas, Matthias Rose & Felix Fischer. (2022) Comparison of the PROMIS Preference Score (PROPr) and EQ-5D-5L Index Value in General Population Samples in the United Kingdom, France, and Germany. Value in Health 25:5, pages 824-834.
Crossref
Crossref
V. N. E. Schuermans, A. Y. J. M. Smeets, A. F. M. Boselie, O. Zarrouk, S. M. M. Hermans, R. Droeghaag, I. Curfs, S. M. A. A. Evers & H. van Santbrink. (2022) Cost-effectiveness of anterior surgical decompression surgery for cervical degenerative disk disease: a systematic review of economic evaluations. European Spine Journal 31:5, pages 1206-1218.
Crossref
Crossref
Siti Norain Azahar, Saperi Sulong, Wan Asyraf Wan Zaidi, Norliza Muhammad, Yusof Kamisah & Norliana Masbah. (2022) Direct Medical Cost of Stroke and the Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation-Related Stroke: A Cross-Sectional Study. International Journal of Environmental Research and Public Health 19:3, pages 1078.
Crossref
Crossref
Brian T. Yates. (2021) Toward collaborative cost-inclusive evaluation: Adaptations and transformations for evaluators and economists. Evaluation and Program Planning 89, pages 101993.
Crossref
Crossref
Raushan Kumar Chaudhary, Melwin Johns Philip, Ashly Santhosh, Satish S. Karoli, Ramesh Bhandari & M.S. Ganachari. (2021) Health economics and effectiveness analysis of generic anti-diabetic medication from jan aushadhi: An ambispective study in community pharmacy. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15:6, pages 102303.
Crossref
Crossref
Claudia C. Dobler, Gordon H. Guyatt, Zhen Wang & M. Hassan Murad. (2021) Users’ Guide to Medical Decision Analysis. Mayo Clinic Proceedings 96:8, pages 2205-2217.
Crossref
Crossref
Brittany Lee KarasMary Frances PiconeShannon WernerMegan Holsopple. (2021) Verifying the value of existing frameworks for formulary review at a large academic health system: assessing inter-rater reliability. Journal of Managed Care & Specialty Pharmacy 27:4, pages 488-496.
Crossref
Crossref
Inge J. M. H. Caelers, Suzanne L. de Kunder, Kim Rijkers, Wouter L. W. van Hemert, Rob A. de Bie, Silvia M. A. A. Evers & Henk van Santbrink. (2021) Comparison of (Partial) economic evaluations of transforaminal lumbar interbody fusion (TLIF) versus Posterior lumbar interbody fusion (PLIF) in adults with lumbar spondylolisthesis: A systematic review. PLOS ONE 16:2, pages e0245963.
Crossref
Crossref
Konstantinos Zisis, Panagiota Naoum & Kostas Athanasakis. (2020) Qualitative comparative analysis of health economic evaluation guidelines for health technology assessment in European countries. International Journal of Technology Assessment in Health Care 37:1.
Crossref
Crossref
Andrea Carta & Claudio Conversano. (2020) On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers. Frontiers in Public Health 8.
Crossref
Crossref
Jue Lie KimSoo-Jeong ChoSu Jin ChungAyoung LeeJinju ChoiHyunsoo ChungSang Gyun Kim. (2020) Empiric Versus Clarithromycin Resistance–Guided Therapy for Helicobacter pylori Based on Polymerase Chain Reaction Results in Patients With Gastric Neoplasms or Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Randomized Controlled Trial. Clinical and Translational Gastroenterology 11:9, pages e00194.
Crossref
Crossref
Sharon Hetherington, Paul Swinton, Tim Henwood, Justin Keogh, Paul Gardiner, Anthony Tuckett, Kevin Rouse & Tracy Comans. (2020) Progressive Resistance Plus Balance Training for Older Australians Receiving In-Home Care Services: Cost-Effectiveness Analyses Alongside the Muscling Up Against Disability Stepped-Wedge Randomized Control Trial. Journal of Aging and Physical Activity 28:3, pages 352-359.
Crossref
Crossref
Valerie Andrees, Swen M. John, Albert Nienhaus, Christoph Skudlik, Richard Brans, Matthias Augustin & Magdalene Krensel. (2020) Economic evaluation of a tertiary prevention program for occupational skin diseases in Germany. Contact Dermatitis 82:6, pages 361-369.
Crossref
Crossref
Bradley R. Hall, Andrew Cannon, Pranita Atri, Christopher S. Wichman, Lynette M. Smith, Sushil Kumar, Surinder K. Batra, Hongmei Wang, Apar Kishor Ganti, Aaron R. Sasson & Chandrakanth Are. (2020) A Comparative Analysis of Survival and Funding Discrepancies in Cancers With High Mortality. Annals of Surgery 271:2, pages 296-302.
Crossref
Crossref
Faramarz Karimian. (2019) A commentary on: “Cost-effectiveness of a national quality improvement programme to improve survival after emergency abdominal surgery” (Int J Surg 2019; 70: 35–43). International Journal of Surgery 72, pages 128-129.
Crossref
Crossref
Mohammadreza Amirsadri, Sarah Mousavi & Ali Karimipour. (2019) The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran. DARU Journal of Pharmaceutical Sciences 27:2, pages 627-634.
Crossref
Crossref
Sarah Paganini, Jiaxi Lin, Fanny Kählke, Claudia Buntrock, Delia Leiding, David D Ebert & Harald Baumeister. (2019) A guided and unguided internet- and mobile-based intervention for chronic pain: health economic evaluation alongside a randomised controlled trial. BMJ Open 9:4, pages e023390.
Crossref
Crossref
Chi Heon Kim, Chun Kee Chung, Myo Jeong Kim, Yunhee Choi, Min-Jung Kim, Sukyoun Shin, Jong-Myung Jung, Sung Hwan Hwang, Seung Heon Yang, Sung Bae Park & Jun Ho Lee. (2018) Increased Volume of Surgery for Lumbar Spinal Stenosis and Changes in Surgical Methods and Outcomes: A Nationwide Cohort Study with a 5-Year Follow-Up. World Neurosurgery 119, pages e313-e322.
Crossref
Crossref
Fanny Kählke, Claudia Buntrock, Filip Smit, Matthias Berking, Dirk Lehr, Elena Heber, Heleen Riper & David Daniel Ebert. (2018) Economic evaluation of an internet-based stress-management intervention alongside an RCT (Preprint). JMIR Mental Health.
Crossref
Crossref
Marian Loveday, Kristina Wallengren, Tarylee Reddy, Donela Besada, James C. M. Brust, Anna Voce, Harsha Desai, Jacqueline Ngozo, Zanele Radebe, Iqbal Master, Nesri Padayatchi & Emmanuelle Daviaud. (2018) MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care. PLOS ONE 13:4, pages e0196003.
Crossref
Crossref
Chi Heon Kim, Chun Kee Chung, Myo Jeong Kim, Yunhee Choi, Min-Jung Kim, Seokyung Hahn, Sukyoun Shin, Jong-myung Jong & Jun Ho Lee. (2018) Increased Volume of Lumbar Surgeries for Herniated Intervertebral Disc Disease and Cost-Effectiveness Analysis. Spine 43:8, pages 585-593.
Crossref
Crossref
Affan Shoukat, Robert Van Exan & Seyed M. Moghadas. (2018) Cost-effectiveness of a potential vaccine candidate for Haemophilus influenzae serotype ‘a’. Vaccine 36:12, pages 1681-1688.
Crossref
Crossref
Samuel Alan Stewart, Amelia O. Clive, Nick A. Maskell & Erika Penz. (2018) Evaluating quality of life and cost implications of prophylactic radiotherapy in mesothelioma: Health economic analysis of the SMART trial. PLOS ONE 13:2, pages e0190257.
Crossref
Crossref
Veena Shankaran, Jesse D. Ortendahl, Anna G. Purdum, Bjorn Bolinder, Ayanna M. Anene, Gordon H. Sun & Tanya G.K. Bentley. (2018) Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States. American Journal of Clinical Oncology 41:1, pages 65-72.
Crossref
Crossref
Martin Bongartz, Rainer Kiss, Phoebe Ullrich, Tobias Eckert, Jürgen Bauer & Klaus Hauer. (2017) Development of a home-based training program for post-ward geriatric rehabilitation patients with cognitive impairment: study protocol of a randomized-controlled trail. BMC Geriatrics 17:1.
Crossref
Crossref
Charles Fontaine, Jean-Pierre Daurès & Paul Landais. (2017) On the censored cost-effectiveness analysis using copula information. BMC Medical Research Methodology 17:1.
Crossref
Crossref
Chadi Nabhan & Bruce A. Feinberg. (2017) Value-Based Calculators in Cancer: Current State and Challenges. Journal of Oncology Practice 13:8, pages 499-506.
Crossref
Crossref
Christian Owesen, Eline Aas & Asbjørn Årøen. (2017) Surgical reconstruction is a cost-efficient treatment option for isolated PCL injuries. Knee Surgery, Sports Traumatology, Arthroscopy.
Crossref
Crossref
Marilena Flouri, Shuyan Zhai, Thomas Mathew & Ionut Bebu. (2017) Tolerance limits and tolerance intervals for ratios of normal random variables using a bootstrap calibration. Biometrical Journal 59:3, pages 550-566.
Crossref
Crossref
Beatriz Guglieri-López, Alejandro Pérez-Pitarch, Begoña Porta Oltra, Francisco Ferriols-Lisart, Ángeles Royo-Peiró & Mónica Climente-Martí. (2016) Effectiveness, toxicity, and economic evaluation of ipilimumab for the treatment of patients with metastatic melanoma in the Spanish outpatient setting. Anti-Cancer Drugs 27:7, pages 679-684.
Crossref
Crossref
Laura N. Gitlin, Catherine Verrier Piersol, Nancy Hodgson, Katherine Marx, David L. Roth, Deidre Johnston, Quincy Samus, Laura Pizzi, Eric Jutkowitz & Constantine G. Lyketsos. (2016) Reducing neuropsychiatric symptoms in persons with dementia and associated burden in family caregivers using tailored activities: Design and methods of a randomized clinical trial. Contemporary Clinical Trials 49, pages 92-102.
Crossref
Crossref
Virginia P. Teti, Seden Akdagli & Sam P. Most. (2016) Cost-effectiveness of Corticosteroid Nasal Spray vs Surgical Therapy in Patients With Severe to Extreme Anatomical Nasal Obstruction. JAMA Facial Plastic Surgery 18:3, pages 165-170.
Crossref
Crossref
Zoie Shui-Yee Wong, David Goldsman & Kwok-Leung Tsui. (2016) Economic Evaluation of Individual School Closure Strategies: The Hong Kong 2009 H1N1 Pandemic. PLOS ONE 11:1, pages e0147052.
Crossref
Crossref
Laura M. YeeKwun Chuen Gary Chan. (2015) Nonparametric inference for time-dependent incremental cost-effectiveness ratios. Statistics in Medicine 34:30, pages 4057-4069.
Crossref
Crossref
Beatriz Guglieri-López, Alejandro Pérez-Pitarch, Begoña Porta-Oltra, Francisco Ferriols-Lisart, Mónica Climente-Martí & Manuel Alós-Almiñana. (2015) Effectiveness, toxicity, and economic evaluation of vinflunine for the treatment of patients with transitional cell carcinoma in the Spanish outpatient setting. Anti-Cancer Drugs 26:8, pages 860-865.
Crossref
Crossref
Insiya B. Poonawalla, David R. Lairson, Wenyaw Chan, Linda B. Piller & Xianglin L. Du. (2015) Cost-Effectiveness of Neoadjuvant Chemotherapy versus Primary Surgery in Elderly Patients with Advanced Ovarian Cancer. Value in Health 18:4, pages 387-395.
Crossref
Crossref
Maxwell Ayindenaba Dalaba, Patricia Akweongo, Raymond Akawire Aborigo, Happiness Pius Saronga, John Williams, Antje Blank, Jens Kaltschmidt, Rainer Sauerborn & Svetla Loukanova. (2015) Cost-Effectiveness of Clinical Decision Support System in Improving Maternal Health Care in Ghana. PLOS ONE 10:5, pages e0125920.
Crossref
Crossref
Gabriel Tremblay, Patrick Haines & Andrew Briggs. (2015) A Criterion-based Approach for the Systematic and Transparent Extrapolation of Clinical Trial Survival Data. Journal of Health Economics and Outcomes Research 2:2, pages 147-169.
Crossref
Crossref